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Abstract Glycolipid biosurfactant (GLB) from
Rhodococcus ruber IEGM 231 was found to stimu-
late tumor necrosis factor-a (TNF-a), interleukin (IL)
-1b and IL-6 production when applied as an ultra-
sonic emulsion to the adherent human peripheral
blood monocyte culture. However, a lack of cytokine-
stimulating activity was registered with the GLB
applied as a hydrophobic film coating in 24-well
culture plates, indicating that it may have been due to
its inhibitory effect on monocyte adhesion. The mode
of GLB application may therefore play an important
role in in vitro assay of immunostimulatory activity
of this compound as well as other bacterial glycolip-
ids. Additionally, GLB from R. ruber displayed no
cytotoxicity against human lymphocytes and there-
fore could be proposed as a potential immunomod-
ulating and antitumor agent.
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Abbreviations
GLB Glycolipid biosurfactant
TNF Tumor necrosis factor
IL Interleukin
TDM Trehalose-6,6’-dimycolate
IEGM Institute of Ecology and Genetics of
Microorganisms
ELISA Enzyme-linked immunosorbent assay
LPS Lipopolysaccharide
Introduction
Microbial glycolipid surfactants show biological
activities towards various organisms ranging from
prokaryotes to mammals. Such activities are deter-
mined by complicated but naturally selected structures
of glycolipid biosurfactants allowing them to display
more versatile properties compared to conventional
chemical surfactants (Kitamoto et al. 2002). Amphi-
philic molecules of glycolipids contain various carbo-
hydrates (e.g. rhamnose, sophorose, mannose, and
trehalose) as a hydrophilic moiety attached to a
hydrophobic moiety represented by various fatty acids,
e.g. saturated, unsaturated, branched, or hydroxylated.
Microbial glycolipids such as rhamnolipids from
Pseudomonas aeruginosa and mannosylerythritol
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lipids from Pseudozyma candida have been investi-
gated for their possible biomedical applications
(Rodrigues et al. 2006). Mycolata group actinobac-
teria, particularly members of the genera Corynebac-
terium, Mycobacterium, Nocardia, Gordonia and
Rhodococcus, are characterized by high cell lipid
concentration (30–60% of dry cell mass) and the
presence of long-chain a-branched b-hydroxylated
fatty (mycolic) acids (Chun et al. 1996). Mycolic
acids are present in the cell envelope in a free state
and as components of glycolipids. Surface-active
trehalose di- and monomycolates of pathogenic (M.
tuberculosis, C. diphtheriae) and opportunistic (M.
avium—M. intracellulare group, N. asteroids, C.
matruchotii, C. xerosis) mycolata play a key role in
the pathogenesis of infections caused by these
actinobacteria and are characterized by pronounced
immunomodulating effects (Ryll et al. 2001). Bio-
logical activity of these glycolipid biosurfactants
(GLBs) is significant, but apparent or potential
pathogenicity of the producer strains and high
toxicity of produced glycolipids hinder their biomed-
ical applications (Sakaguchi et al. 2000; Franzetti
et al. 2010). Therefore, the search for GLB producers
among nonpathogenic actinobacteria is of impor-
tance. In our earlier studies, the GLB produced by a
nonpathogenic Rhodococcus ruber strain was
obtained; its chemical structure and surfactant prop-
erties were investigated (Kuyukina et al. 2001; Philp
et al. 2002). It was found that the GLB from R. ruber
IEGM 231 stimulates in vivo and in vitro immune
response (Kuyukina et al. 2007; Chereshnev et al.
2010).
In vitro detection of immunomodulatory activity
of bacterial glycolipids is complicated by the rela-
tively high hydrophobicity of their molecules. For
immunological analysis, water insoluble glycolipids
are dissolved in organic solvents, e.g. chloroform,
methanol, or oil-in-water emulsions are prepared with
the mineral oil and chemical surfactants, e.g., Tween
80 (Tsuji et al. 2000; Uehori et al. 2003; Novik et al.
2005). As was shown by Yarkoni and Rapp (1978),
the toxicity and biological activity of trehalose-6,6’-
dimycolate (TDM) from M. tuberculosis depend on
the size distribution of the emulsion oil droplets.
Therefore, we have used an ultrasonic emulsion of
the GLB from R. ruber in water to provide a highly
dispersed emulsion with uniform oil droplets (Ku-
yukina et al. 2007). Due to emulsifying activity of the
crude GLB and the presence of neutral lipids in its
composition (Kuyukina et al. 2001), it was possible to
obtain a stable oil-in-water emulsion without mineral
oil, solvent, chemical surfactant, or other potentially
toxic reagent additions.
In some new in vitro protocols, to study the
cytokine-stimulating activity of TDM, murine neu-
trophils and macrophages were incubated in TDM-
coated microplates (Sakaguchi et al. 2000; Okamoto
et al. 2006; Ozeki et al. 2006) and onto TDM-coated
coverslips (Lima et al. 2001). This method avoids the
emulsification procedure and allows preparation of
stock TDM-coated microplates or coverslips, which
could be stored and used in mass immunological
tests. We supposed, though, that an application of
TDM or other glycolipids as a hydrophobic film on
the surface of microplates or coverslips could prevent
the adhesion of human or animal cells tested and
therefore influence their cytokine production. Numer-
ous in vitro experiments (Hofsli et al. 1988; Petit-
Bertron et al. 2003; Pomorski et al. 2004) have
reported that monocyte adherence induces expression
of cytokine (TNF, IL-1b, IL-8) genes and potentiates
monocyte responsiveness to activating signals. It was
also reported (Rodrigues et al. 2006) that microbial
glycolipid biosurfactants possess anti-adhesive activ-
ity against various bacteria and yeasts. To verify the
proposal suggested, we have studied monocyte
adhesion to the GLB-covered and uncovered micro-
plates and also compared their spontaneous and LPS-
induced cytokine production.
The purpose of the present study was to compare
two methods for in vitro assay of GLB immunostim-
ulatory activity using 24-well plates, particularly,
hydrophobic film coating and ultrasonic emulsion
application. The cytotoxicity of the GLB for human
lymphocytes was also investigated.
Materials and methods
GLB preparation
The GLB was extracted from n-dodecane-grown
culture of R. ruber IEGM 231 with methyl tertiary-
butyl ether and partly purified as described elsewhere
(Kuyukina et al. 2001). Structural elucidation of the
GLB revealed a complex of trehalose mycolates with
various alkyl chain lengths (Philp et al. 2002). The
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GLB crude extract contained, apart from glycolipids,
44% non-polar lipids including acylglycerols and free
fatty acids (Kuyukina et al. 2001). The GLB samples
were kept at -20 C under nitrogen until used.
Ultrasonic emulsions containing various concentra-
tions of the GLB were prepared in RPMI 1640
medium (ICN) by sonication (23 kHz, 10 s).
Isolation of monocyte-enriched peripheral blood
cells
Venous blood from healthy male volunteers aged from
22 to 30 was centrifuged in a ficoll-verografin density
gradient. Peripheral blood mononuclear cells were
then washed and resuspended in RPMI 1640 medium.
The cell suspension was incubated for 45 min at 37 C
in a plastic dish at the cell density of 106 cells/mL.
Nonadherent cells were then removed, and the adher-
ent cells were used as monocyte-enriched peripheral
blood mononuclear cells. These cells were suspended
in RPMI 1640 supplemented with 10 mM HEPES
(Sigma), 2 mM L-glutamine (Sigma), 100 lg/mL
gentamicin and 10% fetal calf serum (FCS, ICN).
Cytokine production stimulation assay
In one experiment, 100-lL aliquots of freshly
prepared GLB (1, 10, 100 and 1,000 lg/mL) ultra-
sonic emulsions in RPMI 1640 were placed into
24-well, flat-bottom polystyrene culture plates
(Orange Scientific, Belgium) containing adherent
monocyte cultures (106 cells/mL, 900 lL). As con-
trols, 100-lL aliquots of RPMI 1640 medium were
added to monocyte-containing plates.
In another experiment, the GLB was applied as a
hydrophobic film coating in 24-well plates. GLB-
coated plates were prepared as described by Sakag-
uchi et al. (2000). Namely, the GLB was dissolved in
isopropanol to the concentrations of 1, 10, 100 and
1,000 lg/mL (similar to those used for emulsion
preparation), and 100-lL aliquots were placed into
wells. The plates were allowed to dry in a sterile
atmosphere overnight. The monocytes (106 cells/mL,
1 mL) were then added to GLB-coated and uncoated
(control) plates.
Some monocyte cultures were simultaneously incu-
bated with GLB and lipopolysaccharide (LPS). The
LPS from Salmonella enterica serotype typhimurium
(Sigma, Cat. #L6143) was added in a concentration of
1 lg/mL either with GLB-emulsions to the adhered
monocytes or with a monocyte suspension to the GLB-
coated plates.
All plates were incubated in humidified atmo-
sphere with 5% CO2 at 37 C for 24 h. The
supernatants were collected and stored at -20 C.
Cytokines released in the supernatants were measured
using ELISA kits for IL-1, IL-6 and TNF-a (Vector-
Best, Novosibirsk, Russia).
Adhesion test
For the adherence assay, the GLB was applied as a
hydrophobic film coating in 96-well polystyrene flat-
bottom microplates (Costar) as previously described
for 24-well plates. Final GLB concentrations (1, 10
and 100 lg/mL) were similar to ones used in
cytokine production assay. Uncoated microplates
were used as controls. A monocyte suspension in
RPMI 1640 medium (106 cells/mL, 100 lL) was
added to microplate wells. Microplates were incu-
bated in humidified atmosphere with 5% CO2 at
37 C for 24 h. After the RPMI 1640 medium with
non-adherent cells was carefully removed from the
wells, the adherent monocytes were fixed with 96%
ethanol or 1% glutardialdehyde, stained with crystal
violet for 20 min, washed with H2O and dried. For
the quantitative analysis of cell adhesion, the dye was
dissolved in 100 lL of ethanol–water-acetic acid
(50:49.9:0.1), and the microplates were examined
with a microplate reader (Multiskan Ascent, Thermo
Labsystems, Finland) at 450 nm.
Cytotoxicity test
In vitro toxicity of the GLB was assessed by
measuring the inhibition of proliferative activity of
cultured human peripheral blood lymphocytes. Lym-
phocytes were isolated from the same blood source as
monocytes. After the erythrocytes in blood samples
were allowed to sediment, the buffy coat layer was
centrifuged at 1,500 rpm for 20 min, resuspended in
RPMI 1640, and used for lymphocyte culture.
Lymphocyte cultures (2 9 106 cells/mL, 100 lL) in
RPMI 1640 with added 10 mM HEPES (Sigma),
2 mM L-glutamine (Sigma), 100 lg/mL gentamicin,
and 10% FCS (ICN) were placed into 96-well
polystyrene round-bottom microplates (Medpolymer,
St.-Petersburg, Russia). Freshly prepared emulsions
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(100 lL) of the GLB (adjusted to the final concen-
trations of 0.01, 1, 100 and 10,000 lg/mL) in RPMI
1640 were added to the cultures. Microplates were
incubated in humidified atmosphere with 5% CO2 at
37 C for 72 h. The cells were labeled with 2 lCi of
[3H]thymidine (Isotope, St.-Petersburg, Russia) for
an additional 18 h and measured using a Guardian
liquid scintillation counter (Wallac).
Statistical analysis
Data in tables and figures are presented as
means ± standard errors. Differences between groups
were analyzed using the paired 2-way ANOVA and
Student’s t test. Results were considered significant at
P \ 0.05.
Results
Human peripheral blood monocytes were analyzed in
vitro for spontaneous and LPS-stimulated cytokine
production in response to GLB applied as an
ultrasonic emulsion or a hydrophobic film (Fig. 1a).
It was found that monocytes incubated with GLB
emulsions released significantly higher levels of
cytokines compared to control (no GLB) monocyte
cultures. Similar stimulatory effects were observed
with three different GLB concentrations (0.1, 1 and
10 lg/mL), while the higher (100 lg/mL) concentra-
tion tested resulted in decrease of TNF-a and IL-1b
levels almost to the control values.
In contrast, the GLB applied as a hydrophobic film in
all tested concentrations exhibited the lack of stimula-
tory effect on cytokine production by monocytes. Cells
released significantly lower TNF-a, IL-1b and IL-6
levels when incubated in GLB-coated microplates
compared to cells incubated in the presence of GLB
emulsions. Moreover, the cytokine levels produced by
monocytes in GLB-coated microplates were as low as
those produced by control (no GLB) cells.
Simultaneous monocyte incubation with both GLB
and LPS had no significant effects on cytokine
secretion (Fig. 1b) compared to the effect of LPS
alone. However, control values for LPS-stimulated
cytokine production were significantly higher than that
of non-stimulated monocytes (see Fig. 1a), suggesting
high monocyte activation by cell-wall components of
the pathogenic bacterium S. enterica. The mode of
GLB application, either as film coating or emulsion,
seemed to have no effect on LPS-stimulated cells,
except the significant increase in TNF-a production of
monocytes incubated with 0.1 lg/mL of GLB emul-
sion compared to GLB film. Also, the GLB in
concentration of 100 lg/mL inhibited LPS-induced
production of TNF-a when applied as an emulsion, and
inhibited LPS-induced production of IL-1b when
applied as a film coating or emulsion.
Adhesion has been shown to play an important role
in monocyte and macrophage cellular activity and to
induce their in vitro and in vivo cytokine production
(Petit-Bertron et al. 2003). We have studied the
influence of GLB hydrophobic film on monocyte
adhesion to 96-well microplates. As shown in Fig. 2,
there was an evident inhibition of cell adhesion to
GLB-covered wells; clear free of cells zones appeared
alongside with dark spots of conglutinated mass of
monocytes. In contrast, homogenous layers of mono-
cytes adherent to plastic surfaces were observed in
control (no GLB) wells. Furthermore, GLB emulsion
added in similar concentration did not affect smooth
monocyte layer adherent to plastic (data not shown).
The GLB-inhibiting effect on monocyte adhesion was
found to be concentration-dependant (Fig. 3). Partic-
ularly, 50–60% decrease in cell adhesion was regis-
tered when the GLB applied in concentrations
1–10 lg/mL (similar to concentrations used in cyto-
kine production experiments), compared to control (no
GLB addition) monocyte cultures.
In vitro toxicity of the GLB was assessed from the
inhibition of human peripheral blood lymphocyte
growth. Results on cultured lymphocyte proliferative
activity in the lymphocyte blast transformation test
(Fig. 4) showed no inhibitory effect of the GLB
(10-2 to 104 lg/mL) on 3H-thymidine incorporation
in cell cultures. Furthermore, small but statistically
insignificant lymphocyte stimulation was observed
with the maximum tested GLB concentration (10 mg/
mL). These data confirmed our previous results
(Kuyukina et al. 2007) showing the lack of in vivo
toxicity of the GLB.
Discussion
We found that GLB from Rhodococcus ruber had
stimulated TNF-a, IL-1b and IL-6 production when
applied as an ultrasonic emulsion to an adherent
562 Cytotechnology (2011) 63:559–566
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human peripheral blood monocyte culture. These
findings correlate with our previous results showing
increased secretion of IL-1b, TNF-a (Kuyukina et al.
2007), and IL-12 (Chereshnev et al. 2010) by mono-
cytes in the presence of GLB emulsion. However, lack
of cytokine-stimulating activity was registered with
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Fig. 1 Spontaneous (a) and LPS-stimulated (b) production of
TNF-a, IL-1b and IL-6 by human blood monocytes cultivated
in the presence of GLB applied as a hydrophobic film (white
columns) or ultrasonic emulsion (black columns). Control (no
GLB) monocyte cultures (hatched columns) were cultivated
without LPS (a) or with 1 lg/mL LPS (b). GLB concentrations
are 0.1, 1, 10 and 100 lg/mL. Data represent means ± SD
from 6 experiments. Significant differences (*, P \ 0.05) in
cytokine production were found between GLB-stimulated and
control monocyte cultures; significant differences (#, P \ 0.05)
in cytokine production were found between monocyte cultures
incubated with GLB emulsion and hydrophobic film
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GLB applied as a hydrophobic film to monocyte
suspension. We have hypothesized that low cytokine
production was due to GLB inhibitory effect on
monocyte adhesion. Indeed, cytokine levels produced
by monocytes incubated in GLB-coated microplates
were as low as those produced by non-stimulated
cells. It was also found that a GLB-covering film
partly prevents monocyte adhesion to plastic. How-
ever, our findings are in controversy with the
published results (Sakaguchi et al. 2000; Ozeki et al.
2006) showing increased TNF-a release by murine
neutrophils and macrophages after the incubation in
TDM-coated microplates, and with data of Lima et al.
(2001) showing high cytokine (TNF-a, IL-6, 10, 12,
IFN-c) release by murine macrophages incubated in
TDM-covered glass coverslips. One possible expla-
nation for the difference between our and other
authors’ results lies in the fact that cytokine secretion
by monocytes is a complex process requiring both cell
adhesion and exposure to a chemical inducer such as
bacterial antigen or endotoxin (Petit-Bertron et al.
2003). Since the GLB applied as a hydrophobic film
was apparently less available for monocyte receptors
compared to the GLB emulsion, it arose a weaker
cytokine response. In contrast, the LPS introduced
into the GLB-covered plates stimulated the cytokine
production of monocytes at levels similar to those of
control LPS-incubated cells (see Fig. 1B).
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Fig. 2 Inhibition of monocyte adhesion by GLB applied as a
hydrophobic film to 96-well microplates. Wells 1–3, control—
no GLB addition; wells 4—blank; wells 5–7—GLB (1 lg/mL).
Adherent monocytes were fixed with 1% glutardialdehyde
(A) or 96% ethanol (B), stained with crystal violet, washed with
distilled water, and dried
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Fig. 3 Inhibition of monocyte adhesion by GLB. Monocytes
were incubated in microplate wells coated with GLB-film or
uncoated wells (control) for 24 h. After incubation, non-
adherent monocytes were removed and adherent monocytes
were fixed and stained with crystal violet as previously
described. For quantitative analysis of cell adhesion, the dye
was dissolved in ethanol–water-acetic acid (50:49.9:0.1) and
the microplates examined with a microplate reader at 450 nm.
Data are expressed as percentages from control (without GLB)
optical density values, which were defined as 100%. Results
are shown as percentage means ± SD from 12 microplate
wells
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Fig. 4 Effect of GLB on human lymphocyte proliferation.
Ultrasonic emulsions of GLB were added to lymphocyte
cultures. Lymphocytes were incubated for 72 h, labeled for an
additional 18 h with [3H]thymidine, and measured using a
Guardian liquid scintillation counter. 3H-incorporation levels
express proliferative activity of lymphocytes treated with
different concentrations of GLB. Data represent means ± SD
from 7 experiments
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In addition, the GLB from R. ruber seems to be a
relatively less active immunostimulatory agent com-
pared to TDM from M. tuberculosis (Yasuda 1999),
so even at high concentrations, its signaling effect
could not be strong enough to induce cytokine
production of non-adherent monocytes. Furthermore,
dose-dependent TNF-a production by murine macro-
phages incubated in TDM-coated microplates
decreased considerably at higher TDM concentra-
tions (Okamoto et al. 2006; Ozeki et al. 2006)
possibly due to both TDM cytotoxicity and inhibition
of cell adhesion. In our experiments, the GLB applied
at high concentration (100 lg/mL) significantly
decreased TNF-a and IL-1b production of monocytes
(particularly, in the presence of LPS), while it was
not toxic for human peripheral blood lymphocytes in
the range of 0–10 mg/mL. This fact could be
explained by the combined inhibiting effect of LPS
and GLB and needs further investigation.
There are only few reports on human monocyte/
macrophage/neutrophil stimulation in vitro by TDM
or other mycobacterial glycolipids using oil-in-water
emulsions (Tsuji et al. 2000; Uehori et al. 2003;
Franzetti et al. 2010) and glycolipid-coated polysty-
rene beads (Puissegur et al. 2007; Simons et al.
2007); however, there are no similar publications
describing TDM-coated microplate application. As
was shown by Perez et al. (2000), addition of TDM-
coated polystyrene beads led to some interfering
nonspecific stimulation of mice bone marrow-derived
macrophages resulting in increased levels of TNF-a,
IL-1b, IL-6 possibly induced by cell adhesion to the
beads.
In conclusion, the present study reveals the
importance of bacterial glycolipid application mode
for in vitro cytokine-stimulation assay; this is espe-
cially important for biologically active glycolipids
produced by non-pathogenic bacteria (e.g. GLB from
Rhodococcus ruber), having low toxicity and mod-
erate immunostimulatory activity. In our experi-
ments, the GLB-in-water emulsion obtained by
sonication without the use of surfactants or mineral
oil was applied to the monocyte cultures resulting in
statistically significant increase of TNF-a, IL-1b and
IL-6 production. Thus, cytokine stimulating activity
and lack of in vivo/vitro toxicity of GLB from R.
ruber suggest its potential as an immunomodulatory
and antitumor agent.
Acknowledgments This work was supported by the Russian
Academy of Sciences (Molecular and Cell Biology Program),
RF Ministry of Education and Science (grant 16.518.11.7069),
and by the RF President grant for state support of leading
scientific schools.
References
Chereshnev VA, Gein SV, Baeva TA, Galkina TV, Kuyukina
MS, Ivshina IB (2010) Modulation of cytokine secretion
and oxidative metabolism of innate immune effectors by
Rhodococcus biosurfactant. Bull Exp Biol Med 149:
734–738
Chun J, Kang S-O, Hah YC, Goodfellow M (1996) Phylogeny
of mycolic acid-containing actinomycetes. J Ind Micro-
biol 17:205–213
Franzetti A, Gandolfi I, Bestetti G, Smyth TJP, Banat IM
(2010) Production and applications of trehalose lipid
biosurfactants. Eur J Lipid Sci Technol 112:617–627
Hofsli E, Lamvik J, Nissen-Meyer J (1988) Evidence that
tumour necrosis factor (TNF) is not constitutively present
in vivo the association of TNF with freshly isolated
monocytes reflects a rapid in vitro production. Scand J
Immunol 28:435–441
Kitamoto D, Isoda H, Nakahara T (2002) Functions and
potential applications of glycolipid biosurfactants—from
energy-saving materials to gene delivery carriers. J Biosci
Bioeng 94:187–201
Kuyukina MS, Ivshina IB, Philp JC, Christofi N, Dunbar SA,
Ritchkova MI (2001) Recovery of Rhodococcus biosur-
factants using methyl-tertiary butyl ether extraction.
J Microbiol Methods 46:149–156
Kuyukina MS, Ivshina IB, Gein SV, Baeva TA, Chereshnev
VA (2007) In vitro immunomodulating activity of bio-
surfactant glycolipid complex from Rhodococcus ruber.
Bull Exp Biol Med 144:326–330
Lima VMF, Bonato VLD, Lima KM, Dos Santos SA, Dos
Santos RR, Goncgalves EDC, Faccioli LH, Brandao IT,
Rodrigues-Junior JM, Silva CL (2001) Role of trehalose
dimycolate in recruitment of cells and modulation of
production of cytokines and NO in tuberculosis. Infect
Immun 69:5305–5312
Novik GI, Astapovich NI, Pastsyak M, Gam’yan A (2005)
Biological activity of polar lipids from bifidobacteria.
Microbiology 74:678–684
Okamoto Y, Fujita Y, Naka T, Hirai M, Tomiyasu I, Yano I
(2006) Mycobacterial sulfolipid shows a virulence by
inhibiting cord factor induced granuloma formation and
TNF-a release. Microb Pathog 40:245–253
Ozeki Y, Tsutsui H, Kawada N, Suzuki H, Kataoka M, Kod-
ama T, Yano I, Kaneda K, Kobayashi K (2006) Macro-
phage scavenger receptor down-regulates mycobacterial
cord factor-induced proinflammatory cytokine production
by alveolar and hepatic macrophages. Microb Pathog
40:171–176
Perez RL, Roman J, Roser S, Little C, Olsen M, Indrigo J,
Hunter RL, Actor JK (2000) Cytokine message and pro-
tein expression during lung granuloma formation and
Cytotechnology (2011) 63:559–566 565
123
resolution induced by the mycobacterial cord factor tre-
halose-6, 6’-dimycolate. J Interferon Cytokine Res
20:795–804
Petit-Bertron A-F, Fitting C, Cavaillon J-M, Adib-Conquy M
(2003) Adherence influences monocyte responsiveness to
interleukin-10. J Leukoc Biol 73:145–154
Philp JC, Kuyukina MS, Ivshina IB, Dunbar S, Christofi N,
Lang S, Wray V (2002) Alkanotrophic Rhodococcus ru-
ber as a biosurfactant producer. Appl Microbiol Bio-
technol 59:318–324
Pomorski P, Watson JM, Haskill S, Jacobson KA (2004) How
adhesion, migration, and cytoplasmic calcium transients
influence interleukin-1b mRNA stabilization in human
monocytes. Cell Motil Cytoskeleton 57:143–157
Puissegur M-P, Lay G, Gilleron M, Botella L, Nigou J, Mar-
rakchi H, Mari B, Duteyrat J-L, Guerardel Y, Kremer L,
Barbry P, Puzo G, Altare F (2007) Mycobacterial lipo-
mannan induces granuloma macrophage fusion via a
TLR2-dependent, ADAM9- and b1 integrin-mediated
pathway. J Immunol 178:3161–3169
Rodrigues L, Banat IM, Teixeira J, Oliveira R (2006) Biosur-
factants: potential applications in medicine. J Antimicrob
Chemother 57:609–618
Ryll R, Kumazawa Y, Yano I (2001) Immunological properties
of trehalose dimycolate (cord factor) and other mycolic
acid-containing glycolipids—a review. Microbiol Immu-
nol 45:801–811
Sakaguchi I, Ikeda N, Nakayama N, Kato Y, Yano I, Kaneda K
(2000) Trehalose 6, 6’-dimycolate (cord factor)
neovascularization trough vascular endothelial growth
factor production by neutrophiles and macrophages. Infect
Immun 68:2043–2052
Simons MP, Moore JM, Kemp TJ, Griffith TS (2007) Identi-
fication of the mycobacterial subcomponents involved in
the release of tumor necrosis factor-related apoptosis-
inducing ligand from human neutrophils. Infect Immun
75:1265–1271
Tsuji S, Matsumoto M, Takeuchi O, Akira S, Azuma I, Hay-
ashi A, Toyoshima K, Seya T (2000) Maturation of human
dendritic cells by cell wall skeleton of Mycobacterium
bovis bacillus Calmette-Guerin: involvement of toll-like
receptor. Infect Immun 68:6883–6890
Uehori J, Matsumoto M, Tsuji S, Akazawa T, Takeuchi O,
Akira S, Kawata T, Azuma I, Toyoshima K, Seya T
(2003) Simultaneous blocking of human Toll-like recep-
tors 2 and 4 suppresses myeloid dendritic cell activation
induced by Mycobacterium bovis bacillus Calmette-Gu-
erin peptidoglycan. Infect Immun 71:4238–4249
Yarkoni E, Rapp HJ (1978) Toxicity of emulsified trehalose-6,
6’-dimycolate (cord factor) in mice depends on size distri-
bution of mineral oil droplets. Infect Immun 20:856–860
Yasuda K (1999) Complement activation by mycoloyl glyco-
lipids from Mycobacterium tuberculosis and Rhodococcus
ruber. Osaka City Med J 45:159–174
566 Cytotechnology (2011) 63:559–566
123
